About us Pricing ContactSubscribe

J

Jean‐Baptiste Hiriart

Centre Hospitalier Universitaire de BordeauxORCID https://orcid.org/0000-0002-8863-8230

h-index

—

Publications

—

Citations

—

i10-index

—

Impact (2-yr)

—

Top Publications

Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet Oncology20191,630 citations

Jean‐Baptiste Hiriart · Scinovex